Rifampicin

semisynthetic antibiotic derived from Amycolatopsis rifamycinica (previously known as Amycolatopsis mediterranei and Streptomyces mediterranei). Broad antibacterial activity inhibits DNA-dependent RNA polymerase. Therapy of tuberculosis.

General

Type : Drug, Not A\/B H target, Acetate, Natural, Antibiotic

Chemical_Nomenclature : [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

Canonical SMILES : CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C

InChI : InChI=1S\/C43H58N4O12\/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49\/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)\/b12-11+,19-14+,22-13-,44-20+\/t21-,23+,24+,25+,29-,34-,35+,39+,43-\/m0\/s1

InChIKey : JQXXHWHPUNPDRT-WLSIYKJHSA-N

Other name(s) : DB01045  ||  CHEBI:28077  ||  CHEMBL374478  ||  rifampin  ||  Rifadin  ||  Rimactane  ||  Rimactan


MW : 822.9

Formula : C43H58N4O12

CAS_number :

PubChem : 135398735

UniChem : JQXXHWHPUNPDRT-WLSIYKJHSA-N

Target

Structures : No structure

Families : Arylacetamide_deacetylase

References (9)

Title : Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylase - Yasuda_2021_Drug.Metab.Pharmacokinet_39_100397
Author(s) : Yasuda K , Watanabe K , Fukami T , Nakashima S , Ikushiro SI , Nakajima M , Sakaki T
Ref : Drug Metab Pharmacokinet , 39 :100397 , 2021
Abstract :
PubMedSearch : Yasuda_2021_Drug.Metab.Pharmacokinet_39_100397
PubMedID: 34171773

Title : Role of human AADAC on hydrolysis of eslicarbazepine acetate and effects of AADAC genetic polymorphisms on hydrolase activity - Hirosawa_2021_Drug.Metab.Dispos__
Author(s) : Hirosawa K , Fukami T , Tashiro K , Sakai Y , Kisui F , Nakano M , Nakajima M
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , : , 2021
Abstract :
PubMedSearch : Hirosawa_2021_Drug.Metab.Dispos__
PubMedID: 33446525
Gene_locus related to this paper: human-AADAC

Title : Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients - Thomas_2020_Antibiotics.(Basel)_9_307
Author(s) : Thomas L , Sekhar Miraj S , Surulivelrajan M , Varma M , Sanju CSV , Rao M
Ref : Antibiotics (Basel) , 9 : , 2020
Abstract :
PubMedSearch : Thomas_2020_Antibiotics.(Basel)_9_307
PubMedID: 32521634

Title : A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine - Francis_2019_Antimicrob.Agents.Chemother_63_e01964
Author(s) : Francis J , Zvada SP , Denti P , Hatherill M , Charalambous S , Mungofa S , Dawson R , Dorman S , Gupte N , Wiesner L , Jindani A , Harrison TS , Olagunju A , Egan D , Owen A , McIlleron HM
Ref : Antimicrobial Agents & Chemotherapy , 63 : , 2019
Abstract :
PubMedSearch : Francis_2019_Antimicrob.Agents.Chemother_63_e01964
PubMedID: 30670438
Gene_locus related to this paper: human-AADAC

Title : Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans - Yoshida_2018_Eur.J.Pharm.Sci_111_167
Author(s) : Yoshida T , Fukami T , Kurokawa T , Gotoh S , Oda A , Nakajima M
Ref : Eur J Pharm Sci , 111 :167 , 2018
Abstract :
PubMedSearch : Yoshida_2018_Eur.J.Pharm.Sci_111_167
PubMedID: 28966098
Gene_locus related to this paper: canfa-CESDD1 , canfa-f1p6w8 , canlf-e2r2h2

Title : Isolation and characterization of arylacetamide deacetylase in cynomolgus macaques - Uno_2015_J.Vet.Med.Sci_77_721
Author(s) : Uno Y , Hosokawa M , Imai T
Ref : J Vet Med Sci , 77 :721 , 2015
Abstract :
PubMedSearch : Uno_2015_J.Vet.Med.Sci_77_721
PubMedID: 25715734

Title : Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse - Kobayashi_2012_Drug.Metab.Dispos_40_671
Author(s) : Kobayashi Y , Fukami T , Nakajima A , Watanabe A , Nakajima M , Yokoi T
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 40 :671 , 2012
Abstract :
PubMedSearch : Kobayashi_2012_Drug.Metab.Dispos_40_671
PubMedID: 22207054
Gene_locus related to this paper: human-AADAC , mouse-aryla , ratno-aryla

Title : A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity - Shimizu_2012_Drug.Metab.Dispos_40_1183
Author(s) : Shimizu M , Fukami T , Kobayashi Y , Takamiya M , Aoki Y , Nakajima M , Yokoi T
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 40 :1183 , 2012
Abstract :
PubMedSearch : Shimizu_2012_Drug.Metab.Dispos_40_1183
PubMedID: 22415931
Gene_locus related to this paper: human-AADAC

Title : Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine - Nakajima_2011_Biochem.Pharmacol_82_1747
Author(s) : Nakajima A , Fukami T , Kobayashi Y , Watanabe A , Nakajima M , Yokoi T
Ref : Biochemical Pharmacology , 82 :1747 , 2011
Abstract :
PubMedSearch : Nakajima_2011_Biochem.Pharmacol_82_1747
PubMedID: 21856291
Gene_locus related to this paper: human-AADAC